Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    Alkermes | Japan
Show Display Options
Rank Status Study
1 Completed A Study for Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Human Insulin Inhalation Powder;   Drug: Neutral protamine hagedorn insulin
2 Completed A Study for Patients With Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Insulin glargine;   Drug: Human Insulin Inhalation Powder;   Drug: Injectable Insulin

Indicates status has not been verified in more than two years